Pfizer Recalls Anti-Smoking Drug Chantix Over Cancer Concerns: What to Know

Share on Pinterest

• Pfizer has recalled its smoking cessation drug Chantix due to concerns over a potential cancer-causing ingredient.
• Experts say people taking Chantix should continue using the medication until they can talk with their doctor about potential alternatives.
• They also note that the health risks from smoking outweigh the concerns over Chantix.

Pfizer is recalling its anti-smoking drug Chantix after the Food and Drug Administration (FDA) reported that long-term use of the medication can lead to an increased risk of cancer.

FDA officials did add that there is no immediate risk to people taking Chantix and that people using the drug “should continue taking the current medicine until their pharmacist provides a replacement or their doctor prescribes a different treatment.”

The FDA approved the prescription medication in 2006 to help adults quit smoking. It’s typically used for 12 to 24 weeks.

The FDA also pointed out the benefits of quitting smoking still outweigh any cancer risk from taking Chantix.